New
Empaa-L 5/25mg Tablets (Empagliflozin + Linagliptin)
Empaa-L 5/25mg Tablets (Empagliflozin + Linagliptin)
Empaa-L 5/25mg Tablets (Empagliflozin + Linagliptin)
Description
Empaa-L 5/25mg Tablets (Empagliflozin + Linagliptin)
Empaa-L 5/25mg Tablets contain a fixed-dose combination of empagliflozin and linagliptin, indicated for the management of type 2 diabetes mellitus in adults. Empagliflozin works by reducing glucose reabsorption in the kidneys, while linagliptin enhances incretin hormone activity to support better glycemic control. This combination therapy is prescribed when dual-mechanism treatment is required to maintain stable blood glucose levels under medical supervision. Empaa-L 5/25mg is commonly prescribed in Pakistan as part of long-term diabetes management plans based on individual patient needs. Oxygen Pharmacy ensures authentic sourcing, proper storage, and nationwide availability across Pakistan.
